BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kupetsky EA, Mathers AR, Ferris LK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine 2013;61:704-12. [DOI: 10.1016/j.cyto.2012.12.027] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Rani M, Zhang Q, Schwacha MG. Burn wound γδ T-cells support a Th2 and Th17 immune response. J Burn Care Res 2014;35:46-53. [PMID: 24270084 DOI: 10.1097/01.bcr.0000440705.91099.cc] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
2 Brunner PM, Suárez-Fariñas M, He H, Malik K, Wen HC, Gonzalez J, Chan TC, Estrada Y, Zheng X, Khattri S, Dattola A, Krueger JG, Guttman-Yassky E. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep 2017;7:8707. [PMID: 28821884 DOI: 10.1038/s41598-017-09207-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
3 Kwa MC, Silverberg JI. Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data. Am J Clin Dermatol 2017;18:813-23. [DOI: 10.1007/s40257-017-0293-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
4 May BH, Deng S, Zhang AL, Lu C, Xue CC. In silico database screening of potential targets and pathways of compounds contained in plants used for psoriasis vulgaris. Arch Dermatol Res 2015;307:645-57. [PMID: 26142738 DOI: 10.1007/s00403-015-1577-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Brunner PM, Guttman-Yassky E, Leung DY. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 2017;139:S65-76. [PMID: 28390479 DOI: 10.1016/j.jaci.2017.01.011] [Cited by in Crossref: 226] [Cited by in F6Publishing: 212] [Article Influence: 45.2] [Reference Citation Analysis]
6 Bai F, Zheng W, Dong Y, Wang J, Garstka MA, Li R, An J, Ma H. Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis. Oncotarget 2018;9:1266-78. [PMID: 29416693 DOI: 10.18632/oncotarget.22260] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
7 Chlapanidas T, Perteghella S, Leoni F, Faragò S, Marazzi M, Rossi D, Martino E, Gaggeri R, Collina S. TNF-α blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis. Int J Mol Sci 2014;15:13624-36. [PMID: 25101847 DOI: 10.3390/ijms150813624] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
8 Liu Z, Liu H, Xu P, Yin Q, Wang Y, Opoku YK, Yang J, Song L, Sun X, Zhang T, Yu D, Wang X, Ren G, Li D. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice. Biomedicine & Pharmacotherapy 2018;108:1425-34. [DOI: 10.1016/j.biopha.2018.09.178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Qu XA, Freudenberg JM, Sanseau P, Rajpal DK. Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study. Drug Discov Today 2014;19:1364-71. [PMID: 24662034 DOI: 10.1016/j.drudis.2014.03.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
10 Motaei J, Kerachian MA, Mousavi SA, Alimoghadam K, Ghavamzadeh A, Manoochehrabadi S, Ahmadvand M, Yaghmaie M. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study. Ann Hematol 2021. [PMID: 34247256 DOI: 10.1007/s00277-021-04573-1] [Reference Citation Analysis]
11 Rabeony H, Petit-Paris I, Garnier J, Barrault C, Pedretti N, Guilloteau K, Jegou JF, Guillet G, Huguier V, Lecron JC, Bernard FX, Morel F. Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M. PLoS One 2014;9:e101937. [PMID: 25010647 DOI: 10.1371/journal.pone.0101937] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
12 Guo R, Zhang T, Meng X, Lin Z, Lin J, Gong Y, Liu X, Yu Y, Zhao G, Ding X, Chen X, Lu L. Lymphocyte mass cytometry identifies a CD3-CD4+ cell subset with a potential role in psoriasis. JCI Insight 2019;4:125306. [PMID: 30747724 DOI: 10.1172/jci.insight.125306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
13 Zhao X, Li R, Qiao M, Yan J, Sun Q. MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22. Inflammation 2018;41:496-504. [DOI: 10.1007/s10753-017-0705-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Ritzén A, Sørensen MD, Dack KN, Greve DR, Jerre A, Carnerup MA, Rytved KA, Bagger-Bahnsen J. Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors. ACS Med Chem Lett 2016;7:641-6. [PMID: 27326341 DOI: 10.1021/acsmedchemlett.6b00087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rajpal DK, Qu XA, Freudenberg JM, Kumar VD. Mining emerging biomedical literature for understanding disease associations in drug discovery. Methods Mol Biol 2014;1159:171-206. [PMID: 24788268 DOI: 10.1007/978-1-4939-0709-0_11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ungar B, Pavel AB, Robson PM, Kaufman A, Pruzan A, Brunner P, Kaushik S, Krueger JG, Lebwohl MG, Mani V, Fayad ZA, Guttman-Yassky E. A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis. J Allergy Clin Immunol Pract 2020;8:3500-6. [PMID: 32721606 DOI: 10.1016/j.jaip.2020.07.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Wang Y, Zhao J, Di T, Wang M, Ruan Z, Zhang L, Xie X, Meng Y, Lin Y, Liu X, Wang N, Li P. Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway. Int Immunopharmacol 2016;40:410-8. [PMID: 27697724 DOI: 10.1016/j.intimp.2016.09.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Chen H, Liu H, Lu C, Wang M, Li X, Zhao H, Yan Y, Yu W, Han L, Dai Z. PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice. Front Immunol 2017;8:1767. [PMID: 29358932 DOI: 10.3389/fimmu.2017.01767] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
19 Qin X, Chen C, Zhang Y, Zhang L, Mei Y, Long X, Tan R, Liang W, Sun L. Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling. Saudi Pharm J 2017;25:620-4. [PMID: 28579901 DOI: 10.1016/j.jsps.2017.04.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
20 Rosales Santillan M, Morss PC, Porter ML, Kimball AB. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther 2020;20:621-33. [PMID: 32077334 DOI: 10.1080/14712598.2020.1732918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 2015;135:721-8.e6. [PMID: 25579484 DOI: 10.1016/j.jaci.2014.11.023] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 18.1] [Reference Citation Analysis]
22 Chen H, Lu C, Liu H, Wang M, Zhao H, Yan Y, Han L. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Int Immunopharmacol 2017;48:110-7. [PMID: 28499194 DOI: 10.1016/j.intimp.2017.04.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
23 Suzuki E, Mellins ED, Gershwin ME, Nestle FO, Adamopoulos IE. The IL-23/IL-17 axis in psoriatic arthritis. Autoimmun Rev. 2014;13:496-502. [PMID: 24424175 DOI: 10.1016/j.autrev.2014.01.050] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 12.1] [Reference Citation Analysis]
24 Wang J, Wang YM, Ahn HY. Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications. AAPS J 2014;16:938-47. [PMID: 24993574 DOI: 10.1208/s12248-014-9637-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
25 Carrascosa JM, Belinchón I, de-la-Cueva P, Izu R, Luelmo J, Ruiz-Villaverde R. Expert recommendations on treating psoriasis in special circumstances. Actas Dermosifiliogr 2015;106:292-309. [PMID: 25595327 DOI: 10.1016/j.ad.2014.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Malakouti M, Brown GE, Wang E, Koo J, Levin EC. The role of IL-17 in psoriasis. J Dermatolog Treat. 2015;26:41-44. [PMID: 24552504 DOI: 10.3109/09546634.2013.879093] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
27 Campa M, Ryan C, Menter A. An overview of developing TNF-α targeted therapy for the treatment of psoriasis. Expert Opin Investig Drugs 2015;24:1343-54. [PMID: 26289788 DOI: 10.1517/13543784.2015.1076793] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ferreira M, Barreiros L, Segundo MA, Torres T, Selores M, Costa Lima SA, Reis S. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management. Colloids Surf B Biointerfaces 2017;159:23-9. [PMID: 28779637 DOI: 10.1016/j.colsurfb.2017.07.080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
29 He Q, Zhang B, Hu F, Long J, Shi Q, Pi X, Chen H, Li J. Triptolide Inhibits the Proliferation of HaCaT Cells Induced by IL22 via Upregulating miR-181b-5p. Drug Des Devel Ther 2020;14:2927-35. [PMID: 32801634 DOI: 10.2147/DDDT.S254466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]